Labcorp
-
Labcorp strengthens global clinical research footprint with acquisition of MLM Medical Lab
The acquisition brings MLM’s laboratory infrastructure and scientific expertise into Labcorp’s global network, creating a broader platform to support clinical trials across multiple regions.
-
Labcorp launches reflex testing to improve hepatitis D detection in US
Labcorp estimates that between 70,000 and 150,000 people in the US are living with active HDV infection, while fewer than 20% of patients who test positive for hepatitis B are tested for hepatitis D.
-
Labcorp expands precision oncology portfolio with FDA clearance for melanoma test
The approval allows the company’s PGDx elio tissue complete CDx to be used in hospitals and clinical laboratories across the United States to help identify patients who may benefit from targeted treatment.
-
Labcorp partners with Geneoscopy for nationwide commercial rollout of ColoSense
Developed by Geneoscopy and offered commercially through Labcorp, ColoSense is intended for adults aged 45 to 85 years who are considered to have an average risk of colorectal cancer.